We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$195M
Cap. Flow %
4.46%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$41.6M
2
DINO icon
HF Sinclair
DINO
+$6.4M
3
UNH icon
UnitedHealth
UNH
+$3.72M
4
TPYP icon
Tortoise North American Pipeline ETF
TPYP
+$2.48M
5
FANG icon
Diamondback Energy
FANG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Miscellaneous 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
276
Pfizer
PFE
$157B
$3K ﹤0.01%
120
-29,462
-100% -$687K
RCI icon
277
Rogers Communications
RCI
$19.4B
$3K ﹤0.01%
85
-63,235
-100% -$1.66M
FLR icon
278
Fluor
FLR
$7.09B
$2K ﹤0.01%
+45
New +$1.79K
OGN icon
279
Organon & Co
OGN
$3.59B
$2K ﹤0.01%
184
– –
VMEO
280
DELISTED
Vimeo
VMEO
$2K ﹤0.01%
524
– –
ANGI icon
281
Angi Inc
ANGI
$215M
$1K ﹤0.01%
+88
New +$1.27K
ICE icon
282
Intercontinental Exchange
ICE
$86.5B
$1K ﹤0.01%
8
– –
NKE icon
283
Nike
NKE
$53.1B
$1K ﹤0.01%
19
– –
NOC icon
284
Northrop Grumman
NOC
$75.4B
$1K ﹤0.01%
1
– –
RGP icon
285
Resources Connection
RGP
$139M
$1K ﹤0.01%
175
-14,018
-99% -$76.1K
ROST icon
286
Ross Stores
ROST
$71.8B
$1K ﹤0.01%
8
– –
RUSHA icon
287
Rush Enterprises Class A
RUSHA
$5.72B
$1K ﹤0.01%
30
-8,158
-100% -$276K
W icon
288
Wayfair
W
$14.1B
$1K ﹤0.01%
25
– –
CADE
289
DELISTED
Cadence Bank
CADE
– –
-5,488
Closed -$167K
CCI icon
290
Crown Castle
CCI
$31.2B
– –
-855
Closed -$89K
CHRW icon
291
C.H. Robinson
CHRW
$17.9B
$0 ﹤0.01%
2
– –
CRM icon
292
Salesforce
CRM
$206B
– –
-25
Closed -$7K
CVBF icon
293
CVB Financial
CVBF
$4B
– –
-6,044
Closed -$112K
DDOG icon
294
Datadog
DDOG
$82.9B
– –
-1
Closed –
DINO icon
295
HF Sinclair
DINO
$20.3B
– –
-194,667
Closed -$6.4M
FANG icon
296
Diamondback Energy
FANG
$54.5B
– –
-13,173
Closed -$2.11M
FHN icon
297
First Horizon
FHN
$11.3B
– –
-7,347
Closed -$143K
FTV icon
298
Fortive
FTV
$16.7B
$0 ﹤0.01%
3
-1
-25% -$52
HMN icon
299
Horace Mann Educators
HMN
$2B
– –
-2,023
Closed -$86K
KVUE icon
300
Kenvue
KVUE
$34.2B
$0 ﹤0.01%
15
-8,372
-100% -$190K
9 10 11
12
13

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $3.3B AUM 16.21% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $195M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.